Back to search

University of Strathclyde

Investigating novel inhibitors of essential Leishmania mexicana kinases GSK3? and MPK4

Abstract

dc:description.abstract

The superfamily of protein kinases are emerging as valid therapeutic targets for anti-leishmanial drug development. The essential kinase GSK3? regulates cell proliferation, motility, glycogen metabolism and apoptosis. A peptide sequence derived from ubiquitin hydrolase (UBH5) is one of many substrates of GSK3? and was obtained from a strain of Leishmania Mexicana for recombinant expression and affinity purification. Radiometric kinase assays were then used to screen 320 small-molecule chemical inhibitors designed by Lifearc for their ability to inhibit recombinant GSK3? phosphorylation of UBH5. Three chemical small-molecule inhibitors were identified G18, J16 and J22 which inhibited UBH5 peptide substrate phosphorylation in a concentration- dependent manner with IC50 values of 3.0 µM, 1.4 µM and 3.2 µM, respectively. Two compounds Malabaricone B and Malabricone C were extracted from a plant called Myristica malabarica, previously identified as having anti-leishmanial properties, and investigated for their ability to inhibit GSK3? enzymatic activity. Both plant compounds induced concentration-dependent inhibition of GSK3? auto-phosphorylation and UBH5 peptide substrate phosphorylation. Malabaricone B showed an IC50 of 1.5 µM for auto-phosphorylation and an IC50 of 3.8 µM for substrate phosphorylation. Malabaricone C had IC50's of 1.6 µM and 4.2 µM, respectively. Both Malabaricones were type 1 ATP-competitive inhibitors. Leishmania MPK4 is an essential kinase involved in lesion formation and life cyclestage conversion. Recombinant MPK4 was not well expressed in bacteria therefore two expression plasmids were generated in order to express MPK4 in Leishmania for later purification and screening of inhibitors. The plasmids were constructed expressing C-terminal green fluorescent protein (GFP)-tagged LmxMPK4 or N-terminal GFP-tagged and His-tagged LmxMPK4 both containing the selective marker gene conferring blasticidin resistance. The expression plasmids were used for transfection with wild type Leishmania Mexicana promastigotes and a mutant form which contained no genomic copy of LmxMPK4 but instead carried a plasmid containing the LmxMPK4 gene. Appearance of the GFP during fluorescence microscopy suggested the LmxMPK4-GFP fusion protein was expressed. However, an attempt to replace the plasmid containing LmxMPK4 from the mutant form with a GFP-tagged version was unsuccessful indicating the fusion protein was inactive.

Degree

thesis:*
Name dc:type.qualificationname
mres
Level dc:type.qualificationlevel
masters-pg
Grantor dc:publisher.institution
University of Strathclyde
Year dc:date.issued
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Heaney, Natalie
Advisor dc:contributor.advisor
  • Wiese, Martin (Researcher on Leishmania)
Author Identifier dc:creator.authoridentifier
  • 201773743

Rights

Identifiers

dc:identifier.*
Identifier
T15489

Chain of custody

source
Harvested from
University of Strathclyde
Base URL
stax.strath.ac.uk/catalog/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Heaney, Natalie. Investigating novel inhibitors of essential Leishmania mexicana kinases GSK3? and MPK4. masters-pg thesis, University of Strathclyde, 2020. https://stax.strath.ac.uk/concern/theses/1c18df80p